AllianceBernstein’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.43M Buy
118,223
+1,863
+2% +$47.5K ﹤0.01% 1718
2025
Q4
$3.38M Buy
116,360
+3,000
+3% +$76.8K ﹤0.01% 1731
2025
Q3
$2.14M Hold
113,360
﹤0.01% 1969
2025
Q2
$1.59M Hold
113,360
﹤0.01% 2049
2025
Q1
$1.77M Buy
113,360
+2,200
+2% +$31K ﹤0.01% 1971
2024
Q4
$1.55M Hold
111,160
﹤0.01% 2100
2024
Q3
$1.03M Hold
111,160
﹤0.01% 2312
2024
Q2
$1.03M Buy
111,160
+36,460
+49% +$330K ﹤0.01% 2284
2024
Q1
$740K Buy
74,700
+7,440
+11% +$55.5K ﹤0.01% 2413
2023
Q4
$217K Sell
67,260
-5,100
-7% -$13.9K ﹤0.01% 2955
2023
Q3
$384K Sell
72,360
-7,670
-10% -$65.2K ﹤0.01% 2709
2023
Q2
$763K Sell
80,030
-68,470
-46% -$760K ﹤0.01% 2424
2023
Q1
$1.63M Buy
148,500
+110,000
+286% +$1.59M ﹤0.01% 1991
2022
Q4
$570K Buy
38,500
+10,200
+36% +$178K ﹤0.01% 2559
2022
Q3
$541K Hold
28,300
﹤0.01% 2608
2022
Q2
$603K Buy
28,300
+8,000
+39% +$164K ﹤0.01% 2598
2022
Q1
$391K Hold
20,300
﹤0.01% 2772
2021
Q4
$421K Buy
20,300
+1,500
+8% +$29.9K ﹤0.01% 2809
2021
Q3
$449K Hold
18,800
﹤0.01% 2796
2021
Q2
$513K Buy
18,800
+5,100
+37% +$144K ﹤0.01% 2797
2021
Q1
$396K Sell
13,700
-2,100
-13% -$65.6K ﹤0.01% 2775
2020
Q4
$444K Sell
15,800
-59,864
-79% -$1.47M ﹤0.01% 2647
2020
Q3
$2.22M Sell
75,664
-1,700
-2% -$45.4K ﹤0.01% 1795
2020
Q2
$2.34M Buy
77,364
+8,528
+12% +$246K ﹤0.01% 1757
2020
Q1
$2.05M Buy
+68,836
New +$1.85M ﹤0.01% 1657

Other funds holding ARQT